A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection

NCT04781647 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
54
Enrollment
INDUSTRY
Sponsor class

Stopped Study ABI-H0731-203 was terminated early by the study Sponsor for strategic reasons to prioritize research and development efforts on finite and curative HBV therapies.

Conditions

Interventions

Sponsor

Assembly Biosciences